Carl Zeiss Meditec (AFX) PT Set at €92.50 by Hauck & Aufhaeuser

Hauck & Aufhaeuser set a €92.50 ($107.56) price objective on Carl Zeiss Meditec (ETR:AFX) in a research note issued to investors on Monday, April 15th, Borsen Zeitung reports. The firm currently has a buy rating on the stock.

Other equities analysts have also issued reports about the company. Deutsche Bank set a €71.00 ($82.56) target price on Carl Zeiss Meditec and gave the company a neutral rating in a report on Tuesday, February 12th. Nord/LB set a €92.00 ($106.98) price objective on Carl Zeiss Meditec and gave the stock a buy rating in a research note on Monday, February 11th. Independent Research set a €74.00 ($86.05) price objective on Carl Zeiss Meditec and gave the stock a sell rating in a research note on Wednesday, February 13th. Berenberg Bank set a €68.00 ($79.07) price objective on Carl Zeiss Meditec and gave the stock a neutral rating in a research note on Monday, February 11th. Finally, HSBC set a €80.00 ($93.02) price objective on Carl Zeiss Meditec and gave the stock a neutral rating in a research note on Thursday, February 14th. Three investment analysts have rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company’s stock. The stock has a consensus rating of Hold and an average price target of €75.63 ($87.94).

Carl Zeiss Meditec stock traded up €1.15 ($1.34) during trading hours on Monday, reaching €86.90 ($101.05). The stock had a trading volume of 123,258 shares, compared to its average volume of 94,405. Carl Zeiss Meditec has a 52 week low of €55.75 ($64.83) and a 52 week high of €88.85 ($103.31). The company has a market capitalization of $7.77 billion and a PE ratio of 61.46.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Recommended Story: Why is the Consumer Price Index (CPI) important?

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.